A significant increase in IOP in the fellow
eye (FE) after glaucoma surgery in the index eye (IE) has been noted by some
researchers. Although, there are also reports of reduction in IOP in the FE
after surgery in the IE.
See post on AMTT here: https://ourgsc.blogspot.com/search?q=AHMAD%27S
In a study performed on 187 consecutive
glaucoma patients, who underwent either trabeculectomy or Ahmed Glaucoma Valve
(AGV) implantation, it was found that nearly a third of them required medical
or surgical management of IOP in the FE following surgery of the IE. [1]
In the study, 87.7% patients underwent
trabeculectomy and 12.3% underwent AGV implantation.
Incidentally, in 84% of the patients the FE
was already glaucomatous and 22 eyes had undergone trabeculectomy.
The mean IOP rise in FE among all patients
(trabeculectomy and AGV), was as follows:
Pre-operative IOP in IE |
17.6± 6.9 (n-187) |
Pre-operative IOP in FE |
14.48± 3.4 (n‑187) |
IOP in FE: Post-op 1 day |
14.54 ± 4.9 (p‑ 0.694) |
Post-op 1 week |
15.8 ± 5.5 (p‑0.005) |
Post-op 1 month |
15.62 ± 5.7 (p‑0.007) |
Post-op 3 months |
15.09 ± 5.0 (n‑135, p‑0.279) |
Among patients with AGV shunt surgery (n=23),
the mean fellow eye IOP was higher than baseline at all‑time points, with
maximum rise on day 1 (15.91 ± 6.3, baseline 13.78 ± 2.7; n‑ 23, p‑0.066).
Pre‑operative acetazolamide (n=43) strongly
predicted a statistically significant increase in FE mean IOP.
Among all patients, 15% required additional
intervention to control IOP in the FE in the first 30 days and 33% in the first
90 days after glaucoma surgery in the IE.
In the trabeculectomy group, 35% patients
required an increase in the anti-glaucoma medications or surgery in the FE,
within 90 days of surgery in the IE.
In the AGV group, 18% patients required
additional intervention in the FE within 90 days of surgery in the IE.
Among all patients, 14.4% eyes required
surgical intervention in the FE.
Other studies have also noted a significant
increase in IOP in the FE after glaucoma surgery. Meshksar reported maximum IOP
rise 1 week after surgery [2], while Kaushik noted it at 6 weeks following
surgery [3].
Incidentally, Kaushik did not report any
significant association with acetazolamide.
A number of explanations have been surmised
for this phenomenon. It is assumed that patients stop the anti-glaucoma
medications in FE after surgery in one eye.
Another potential explanation for the rise
in IOP would be the sequelae of under-perfusion of the scleral meshwork due to
preferential flow through the sclerostomy site. Under-perfusion results in
meshwork densification, activation of endothelial cells and increase in
extracellular matrix both in the ipsilateral and contralateral eye offering
resistance to aqueous outflow and in turn contributing to the rise in
consensual eye IOP.
It has also been postulated that the
scleral spur consists of special cells that play an important role in the
afferent pathway of the reflex that controls bilateral ciliary body and
meshwork contractile tone. Surgery in one eye could affect the other eye
through these cells.
These studies indicate that close
monitoring is required for the consensual eye after glaucoma surgery in one
eye.
REFERENCE:
[1] Rajsrinivas D, Dubey S, Pegu J,
Majumdar A. Consensual eye intra-ocular pressure rise following unilateral
glaucoma surgery. Indian J Ophthalmol. 2023 Mar;71(3):873-879. doi:
10.4103/ijo.IJO_1909_22. PMID: 36872698; PMCID: PMC10230001.
[2] Meshksar A, Hajizadeh M, Sharifipour F,
Yazdani S, Pakravan M, Kheiri B. Intraocular pressure changes in the
contralateral eye after glaucoma surgery. J Glaucoma 2021;30:1074‑81.
[3] Kaushik S, Agarwal A, Kaur S, Lomi N,
Raj S, Pandav SS. Change in intraocular pressure in the fellow eye after
glaucoma surgery in 1 eye. J Glaucoma 2016;25:324–9.
No comments:
Post a Comment